Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yi-Pan Zhu"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
IntroductionBasal cell carcinoma (BCC) is the most common skin cancer, lacking reliable biomarkers or therapeutic targets for effective treatment. Genome-wide association studies (GWAS) can aid in identifying drug targets, repurposing existing drugs,
Externí odkaz:
https://doaj.org/article/c48ee8ed9d024e95979716443b5d9632
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: T cell exhaustion (TEX) heterogeneity leads to unfavorable immunotherapeutic responses in patients with cancer. Classification of TEX molecular phenotypes is pivotal to overcoming TEX and improving immunotherapies in the clinical setting.
Externí odkaz:
https://doaj.org/article/6110cf3e2749415d8d0b6e81f100d9ec
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Externí odkaz:
https://doaj.org/article/392c33032bbf4729ada8f342baf373d0
Autor:
Huan-Yu Zhao, Yi-Pan Zhu, Ying Wen, Xin-Yu Ding, Jing Sun, Ren-Peng Ji, Qiu-Ju Han, Lu-Yuan Li
Publikováno v:
Biochemical pharmacology. 206
Monocyte chemotactic protein-1 (MCP-1) is known to be able to facilitate vascular endothelial growth factor (VEGF) gene expression, hence promoting vascular hyperpermeability and neovascularization. We show here that a microRNA molecule, miR-374b-5p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcfec4d92f30eb2b24da8fd2979fd2ef
https://pubmed.ncbi.nlm.nih.gov/36328133
https://pubmed.ncbi.nlm.nih.gov/36328133